Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyCellularComponentU2-type prespliceosome

SF3B1 LUC7L3

3.21e-0418312GO:0071004
GeneOntologyCellularComponentprespliceosome

SF3B1 LUC7L3

3.21e-0418312GO:0071010
GeneOntologyCellularComponentintracellular protein-containing complex

PSMC6 TRAF3 ERCC3 PHF20L1 POLR3E PRIM1 TADA2B

4.53e-04972317GO:0140535
GeneOntologyCellularComponentnuclear DNA-directed RNA polymerase complex

ERCC3 POLR3E PRIM1

6.19e-04113313GO:0055029
GeneOntologyCellularComponentDNA-directed RNA polymerase complex

ERCC3 POLR3E PRIM1

6.68e-04116313GO:0000428
GeneOntologyCellularComponentRNA polymerase complex

ERCC3 POLR3E PRIM1

7.20e-04119313GO:0030880
GeneOntologyCellularComponenttransferase complex, transferring phosphorus-containing groups

TRAF3 ERCC3 POLR3E PRIM1

1.45e-03335314GO:0061695
GeneOntologyCellularComponentcytoplasmic side of plasma membrane

TRAF3 SPTB MTSS2

2.55e-03185313GO:0009898
GeneOntologyCellularComponenttransferase complex

TRAF3 ERCC3 PHF20L1 POLR3E PRIM1 TADA2B

2.58e-03963316GO:1990234
DomainRHO

RHOBTB1 RHOBTB2

4.35e-0420292PS51420
DomainAAA

PSMC6 VWA8

1.27e-0334292PS00674
DomainP-loop_NTPase

ASPM PSMC6 ERCC3 RHOBTB1 VWA8 RHOBTB2

1.67e-03848296IPR027417
DomainZinc_finger_PHD-type_CS

PHF20L1 PHF3

4.56e-0365292IPR019786
DomainCH

ASPM SPTB

4.56e-0365292SM00033
DomainCH

ASPM SPTB

5.27e-0370292PF00307
Domain-

PSMC6 ERCC3 RHOBTB1 VWA8 RHOBTB2

5.37e-037462953.40.50.300
Domain-

ASPM SPTB

5.41e-03712921.10.418.10
DomainCH

ASPM SPTB

5.71e-0373292PS50021
DomainCH-domain

ASPM SPTB

6.02e-0375292IPR001715
DomainTPR_1

ST13P5 FKBP5

8.57e-0390292PF00515
DomainTPR_1

ST13P5 FKBP5

8.57e-0390292IPR001440
DomainZF_PHD_1

PHF20L1 PHF3

9.70e-0396292PS01359
Pubmed

mTOR Inhibition via Rapamycin Treatment Partially Reverts the Deficit in Energy Metabolism Caused by FH Loss in RPE Cells.

ANKRD12 LUC7L3 VWA8 SPTB

1.76e-069831434943047
Pubmed

Defining the human deubiquitinating enzyme interaction landscape.

PSMC6 USP8 LRRC59 VWA8 POLR3E FKBP5 PRIM1 TADA2B

2.07e-06100531819615732
Pubmed

Atypical Rho GTPases of the RhoBTB Subfamily: Roles in Vesicle Trafficking and Tumorigenesis.

RHOBTB1 RHOBTB2

2.31e-06331227314390
Pubmed

The Dictyostelium discoideum family of Rho-related proteins.

RHOBTB1 RHOBTB2

2.31e-06331211222756
Pubmed

Genomic organization and expression profile of the small GTPases of the RhoBTB family in human and mouse.

RHOBTB1 RHOBTB2

2.31e-06331212426103
Pubmed

Oligogenic heterozygous inheritance of sperm abnormalities in mouse.

CFAP44 CCDC146

4.61e-06431235451961
Pubmed

Histone-binding of DPF2 mediates its repressive role in myeloid differentiation.

PSMC6 LRRC59 SF3B1 LUC7L3 U2SURP

4.92e-0628331528533407
Pubmed

Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.

ASPM SF3B1 PHF3 PRIM1 U2SURP LRRFIP1

4.98e-0650631630890647
Pubmed

Characterization of RhoBTB-dependent Cul3 ubiquitin ligase complexes--evidence for an autoregulatory mechanism.

RHOBTB1 RHOBTB2

7.68e-06531218835386
Pubmed

MUF1/leucine-rich repeat containing 41 (LRRC41), a substrate of RhoBTB-dependent cullin 3 ubiquitin ligase complexes, is a predominantly nuclear dimeric protein.

RHOBTB1 RHOBTB2

1.15e-05631222709582
Pubmed

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.

LRRC59 CEBPB SF3B1 LUC7L3 POLR3E PHF3 U2SURP TADA2B

1.32e-05129431830804502
Pubmed

TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.

LRRC59 ERCC3 SF3B1 LUC7L3 U2SURP LRRFIP1 TADA2B

1.63e-0594931736574265
Pubmed

HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.

LRRC59 ERCC3 SF3B1 LUC7L3 VWA8 PHF3 LRRFIP1 TADA2B

2.00e-05137131836244648
Pubmed

Expression analysis of mouse Rhobtb3 using a LacZ reporter and preliminary characterization of a knockout strain.

RHOBTB1 RHOBTB2

2.15e-05831224923387
Pubmed

Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.

LRRC59 ERCC3 CEBPB SF3B1 PHF3 FKBP5 PRIM1

2.50e-05101431732416067
Pubmed

A20-binding inhibitor of NF-κB (ABIN1) controls Toll-like receptor-mediated CCAAT/enhancer-binding protein β activation and protects from inflammatory disease.

TRAF3 CEBPB

2.76e-05931222011580
Pubmed

A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.

PSMC6 TRAF3 LRRC59 SF3B1 LUC7L3 VWA8 FKBP5 LRRFIP1

2.85e-05144031830833792
Pubmed

A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.

PSMC6 LRRC59 ERCC3 PHF3 LRRFIP1 TADA2B

3.76e-0572431636232890
Pubmed

TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.

SF3B1 LUC7L3 FKBP5 U2SURP

4.29e-0522031435785414
Pubmed

Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.

LRRC59 SF3B1 VWA8 ST13P5 CXADR U2SURP LRRFIP1

5.24e-05113931736417873
Pubmed

High-sensitivity profiling of SARS-CoV-2 noncoding region-host protein interactome reveals the potential regulatory role of negative-sense viral RNA.

LRRC59 SF3B1 POLR3E U2SURP LRRFIP1

5.55e-0546931537314180
Pubmed

PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase.

ASPM CEBPB FKBP5 U2SURP

6.72e-0524731432989298
Pubmed

Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.

PSMC6 LRRC59 SF3B1 LUC7L3 U2SURP LRRFIP1

6.97e-0580931632129710
Pubmed

Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.

PSMC6 LRRC59 ERCC3 SF3B1 PHF3 FKBP5 U2SURP

9.25e-05124731727684187
Pubmed

Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation.

PSMC6 LRRC59 SF3B1 CXADR

9.34e-0526931430442662
Pubmed

Large-scale mapping of human protein-protein interactions by mass spectrometry.

ASPM PSMC6 RIOK3 USP8 LRRC59 SF3B1 LUC7L3

1.11e-04128431717353931
Pubmed

BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.

PSMC6 ATP6V1C1 LRRC59 SF3B1 LUC7L3 FKBP5 U2SURP

1.31e-04131831730463901
Pubmed

The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.

CEBPB SF3B1 POLR3E PHF3 U2SURP

1.54e-0458331529844126
Pubmed

The X-Linked-Intellectual-Disability-Associated Ubiquitin Ligase Mid2 Interacts with Astrin and Regulates Astrin Levels to Promote Cell Division.

ASPM PSMC6

1.76e-042231226748699
Pubmed

Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.

USP8 LRRC59 SF3B1 LUC7L3 VWA8 U2SURP LRRFIP1

2.02e-04141531728515276
Pubmed

NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90.

TRAF3 LRRC59 SF3B1 LRRFIP1

2.12e-0433331432665550
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

ASPM USP8 LRRC59 CFAP210 SF3B1 PHF20L1 U2SURP

2.27e-04144231735575683
Pubmed

Genome-wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence on a Pre-mRNA Metabolic Pathway Regulated by DCPS.

LRRC59 SF3B1 PHF3 U2SURP

2.29e-0434031429478914
Pubmed

BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors.

LUC7L3 U2SURP TADA2B

2.32e-0413431325452129
Pubmed

Inhibition of UBE2D3 expression attenuates radiosensitivity of MCF-7 human breast cancer cells by increasing hTERT expression and activity.

PHF20L1 U2SURP

2.47e-042631223741361
Pubmed

TXLNA enhances TBK1 phosphorylation by suppressing PPM1B recruitment.

LUC7L3 POLR3E U2SURP

2.53e-0413831337506885
Pubmed

MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.

LRRC59 ERCC3 SF3B1 LUC7L3 VWA8 U2SURP

3.38e-04108231638697112
Pubmed

The protein interaction landscape of the human CMGC kinase group.

PSMC6 ERCC3 LUC7L3 PHF3 FKBP5

3.47e-0469531523602568
Pubmed

Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion.

LUC7L3 FKBP5 PRIM1 CXADR TADA2B

3.68e-0470431532994395
Pubmed

Sf3b4 regulates chromatin remodeler splicing and Hox expression.

SF3B1 PHF20L1

3.75e-043231237167859
Pubmed

Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme.

ERCC3 LUC7L3 POLR3E FKBP5

3.86e-0439031417643375
Pubmed

Characterization of novel SF3b and 17S U2 snRNP proteins, including a human Prp5p homologue and an SF3b DEAD-box protein.

SF3B1 U2SURP

4.24e-043431212234937
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

USP8 ANKRD12 PHF3 RHOBTB2

4.53e-0440731412693553
Pubmed

Phosphoinositide-specific phospholipase C β 1b (PI-PLCβ1b) interactome: affinity purification-mass spectrometry analysis of PI-PLCβ1b with nuclear protein.

LRRC59 SF3B1 U2SURP

4.58e-0416931323665500
Pubmed

Tumor suppressor BAP1 nuclear import is governed by transportin-1.

PSMC6 LRRC59 SF3B1 LUC7L3 FKBP5 U2SURP

4.65e-04114931635446349
Pubmed

STRAP regulates alternative splicing fidelity during lineage commitment of mouse embryonic stem cells.

SF3B1 U2SURP

4.75e-043631233230114
Pubmed

Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53.

LRRC59 SF3B1 LUC7L3 U2SURP

5.14e-0442131434650049
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

SF3B1 PHF3 FKBP5 CXADR LRRFIP1

5.67e-0477431515302935
Pubmed

Combinatorial CRISPR screen identifies fitness effects of gene paralogues.

ASPM ATP6V1C1 FKBP5

6.06e-0418631333637726
Pubmed

A germline-specific class of small RNAs binds mammalian Piwi proteins.

LRRC59 ANKRD12 RHOBTB2 SPTB

6.60e-0445031416751776
Pubmed

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.

LRRC59 ERCC3 SF3B1 PHF3 PRIM1 LRRFIP1

7.46e-04125731636526897
Pubmed

RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.

SF3B1 VWA8 LRRFIP1

7.70e-0420231324639526
Pubmed

Tripartite motif-containing protein 11 promotes hepatocellular carcinogenesis through ubiquitin-proteasome-mediated degradation of pleckstrin homology domain leucine-rich repeats protein phosphatase 1.

LUC7L3 U2SURP

7.77e-044631234767673
Pubmed

Folate receptor α increases chemotherapy resistance through stabilizing MDM2 in cooperation with PHB2 that is overcome by MORAb-202 in gastric cancer.

SF3B1 LUC7L3 U2SURP

8.15e-0420631334185411
Pubmed

Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.

PSMC6 SF3B1 ST13P5 U2SURP LRRFIP1

8.50e-0484731535235311
Pubmed

Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach.

PSMC6 ERCC3 U2SURP

8.73e-0421131317314511
Pubmed

Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.

PSMC6 TRAF3 LRRC59 SF3B1 ST13P5 U2SURP

8.79e-04129731633545068
Pubmed

Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.

LRRC59 SF3B1 LUC7L3 U2SURP

8.79e-0448631430940648
InteractionSF3B5 interactions

CEBPB SF3B1 RHOBTB1 U2SURP TADA2B

2.46e-06143315int:SF3B5
InteractionRSL1D1 interactions

LRRC59 CEBPB SF3B1 CFAP44 PHF3 RHOBTB2 U2SURP

6.58e-06479317int:RSL1D1
InteractionAR interactions

PSMC6 ERCC3 CEBPB SF3B1 LUC7L3 PHF3 FKBP5 U2SURP TADA2B

1.24e-05992319int:AR
InteractionPRPF8 interactions

LRRC59 CEBPB SF3B1 LUC7L3 VWA8 FKBP5 U2SURP LRRFIP1

1.67e-05776318int:PRPF8
InteractionTPM3 interactions

PSMC6 CEBPB RHOBTB1 CCDC146 FKBP5 RHOBTB2

2.47e-05390316int:TPM3
InteractionU2AF2 interactions

PSMC6 LRRC59 ERCC3 CEBPB SF3B1 U2SURP LRRFIP1

4.75e-05651317int:U2AF2
InteractionH1-4 interactions

TRAF3 LRRC59 CEBPB SF3B1 PHF3 CXADR U2SURP

4.99e-05656317int:H1-4
InteractionEML4 interactions

PSMC6 LUC7L3 FKBP5 LRRFIP1

5.58e-05137314int:EML4
InteractionPCBP1 interactions

PSMC6 ATP6V1C1 ERCC3 CEBPB PHF3 FKBP5 U2SURP

5.75e-05671317int:PCBP1
InteractionCFH interactions

ANKRD12 LUC7L3 VWA8 SPTB

6.07e-05140314int:CFH
InteractionETF1 interactions

CEBPB RHOBTB1 RHOBTB2 U2SURP

6.41e-05142314int:ETF1
InteractionMCM6 interactions

PSMC6 CEBPB SF3B1 FKBP5 RHOBTB2

7.10e-05287315int:MCM6
InteractionCCDC97 interactions

CEBPB SF3B1 U2SURP

7.75e-0554313int:CCDC97
InteractionDDX23 interactions

LRRC59 CEBPB SF3B1 LUC7L3 PHF3 U2SURP

7.85e-05480316int:DDX23
InteractionMMS19 interactions

ERCC3 CEBPB RHOBTB1 RHOBTB2 PRIM1

1.04e-04311315int:MMS19
InteractionSLBP interactions

USP8 SF3B1 MTSS2

1.48e-0467313int:SLBP
InteractionCRNKL1 interactions

CEBPB SF3B1 RHOBTB1 RHOBTB2

1.50e-04177314int:CRNKL1
InteractionPOLR2C interactions

PSMC6 ERCC3 RHOBTB1 POLR3E PHF3

1.53e-04338315int:POLR2C
InteractionDPF2 interactions

PSMC6 LRRC59 CEBPB SF3B1 LUC7L3

1.78e-04349315int:DPF2
InteractionRPS10 interactions

PSMC6 RIOK3 LRRC59 CEBPB SF3B1 U2SURP

1.95e-04567316int:RPS10
InteractionCOPS5 interactions

PSMC6 ANKRD12 CEBPB SF3B1 RHOBTB1 LUC7L3 RHOBTB2 U2SURP

1.99e-041102318int:COPS5
InteractionABCF1 interactions

PSMC6 TRAF3 LRRC59 CEBPB

2.45e-04201314int:ABCF1
Cytoband17q21.33

LRRC59 LUC7L3

3.56e-044131217q21.33
GeneFamilyRho family GTPases

RHOBTB1 RHOBTB2

2.18e-0420202390
GeneFamilyPHD finger proteins

PHF20L1 PHF3

4.39e-039020288
GeneFamilyBasic leucine zipper proteins|BTB domain containing

RHOBTB1 RHOBTB2

9.49e-03134202861
CoexpressionSHEN_SMARCA2_TARGETS_UP

PSMC6 RIOK3 ERCC3 LUC7L3 PHF3 U2SURP

9.66e-06429316M29
CoexpressionFOSTER_TOLERANT_MACROPHAGE_UP

RIOK3 TRAF3 CFAP210 CXADR

4.27e-05166314M12595
CoexpressionGSE45365_WT_VS_IFNAR_KO_BCELL_MCMV_INFECTION_UP

RHOBTB2 CXADR U2SURP LRRFIP1

6.38e-05184314M9988
CoexpressionFOSTER_TOLERANT_MACROPHAGE_UP

RIOK3 TRAF3 CFAP210 CXADR

6.79e-05187314MM1034
ToppCellASK454-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq

USP8 TRAF3 CFAP210 CFAP44 TADA2B

1.67e-071903055cea6480f08253d7adf484e511d3fdfa96641268
ToppCellPND03|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CEBPB CFAP44 CXADR LRRFIP1

7.28e-06187304b3fcb36d853adfdea7172c5591de06f027e50af3
ToppCellsystemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

ANKRD12 SF3B1 PHF3 FKBP5

9.12e-061983044c93ee921d56132d80832d8e94563f32ccf13bbc
ToppCell(03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition

ANKRD12 PHF3 U2SURP LRRFIP1

9.30e-06199304c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell(09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition

ANKRD12 CCDC146 PHF3 U2SURP

9.30e-06199304fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCellCOVID-19|World / Disease, condition lineage and cell class

RIOK3 ANKRD12 SF3B1 PHF3

9.49e-062003047dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCellE15.5-Hematopoietic-Erythroid-enucleate_erythrocyte|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

RIOK3 NTNG2 SPTB

1.20e-04143303e4207ff9e8248813356631631bbf31a63f23ad3c
ToppCellE15.5-Hematopoietic-Erythroid|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

RIOK3 NTNG2 SPTB

1.20e-0414330315a7b93c381ef0f455f99f3abf4b2b9454d35bc4
ToppCellLPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CFAP210 CFAP44 CCDC146

1.52e-041553035f1e2195a6b831e1b636f5cc3a282ca423721822
ToppCellLPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CFAP210 CFAP44 CCDC146

1.52e-041553030944429459f642a1bcc56edc1ec28aaecde3e2dc
ToppCelldroplet-Liver-Hepatocytes-24m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ASPM CFAP210 SPTB

1.67e-041603039f24ee4fe1ba4590dce5dd4d43707fb007dca82f
ToppCelldroplet-Liver-Hepatocytes-24m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ASPM CFAP210 SPTB

1.67e-041603033b3b99305558f5b49d050fb9b249007630ea9085
ToppCell10x5'-blood-Lymphocytic_Invariant-Inducer-like-ILC3|blood / Manually curated celltypes from each tissue

CXADR SPTB MTSS2

1.83e-04165303f012a27ece54c0f7b73a2f4f89c6ee8b865f8782
ToppCellCiliated_cells-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id

CFAP210 CFAP44 CCDC146

2.07e-04172303187ae91148d293537afc77e10da2b64302322224
ToppCell3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CFAP210 CFAP44 CCDC146

2.10e-04173303c3762655caa79ac4879876f470d32578a3c93b01
ToppCellCiliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id

CFAP210 CFAP44 CCDC146

2.44e-04182303e93968f800bfeb258e4e834fc8bf92d1cb72cd73
ToppCellPND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ERCC3 CFAP210 TADA2B

2.48e-041833033ef9ac1ae13b6172f9121ab1c129ecaa0fef460f
ToppCellfacs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANKRD12 SPTB MTSS2

2.60e-04186303a1ab273b01971d6a892912560d387685dd657179
ToppCelldroplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANKRD12 SF3B1 LRRFIP1

2.64e-04187303663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCellfacs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANKRD12 SPTB MTSS2

2.64e-04187303ef3c85c01bc3da408ae288b6e3096ad888a12e63
ToppCell21-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class

CFAP210 CFAP44 CCDC146

2.64e-041873031a2178a195d078d1963947b327c6d0d4f2f48341
ToppCellCiliated_cells-B-IPF_03|World / lung cells shred on cell class, cell subclass, sample id

CFAP210 CFAP44 CCDC146

2.64e-041873036fa38dbccca36bc7a4fef46de74c6688f599f421
ToppCellmulticiliated|World / shred by cell class for bronchial biopsy

CFAP210 CFAP44 CCDC146

2.68e-041883036833c1f0f265ef5448fa65033550ed7efc2f8d7b
ToppCelldroplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SF3B1 LUC7L3 LRRFIP1

2.68e-04188303d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd
ToppCellEpithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4)

CFAP210 CFAP44 CCDC146

2.68e-041883038f30535a32968a81a304315a49c0d90a77d36948
ToppCellrenal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group

RHOBTB1 LUC7L3 FKBP5

2.72e-04189303a48df46274d51e84ffb40264646de7346104efb9
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CEBPB FKBP5 LRRFIP1

2.72e-0418930355aba1ebc012006a5db3ff9c92589cb3d9f7c68a
ToppCellCOPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class

CFAP210 CFAP44 CCDC146

2.72e-041893033e77883db34722b9ce0a03ea74caefc92dc7feff
ToppCellEpithelial-D_(Ciliated)|World / shred on cell class and cell subclass (v4)

CFAP210 CFAP44 CCDC146

2.72e-041893030bf560b595c7a8450a46bc821b742b67965bd9f9
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

POLR3E PHF3 FKBP5

2.77e-0419030391ba66d4b56c59523485b17738e93f14bb00afa4
ToppCellpdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

ASPM FKBP5 PRIM1

2.77e-04190303d06ee5f89f1cec8db6897fe3b2a890a07cd3697b
ToppCellE16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CFAP210 CFAP44 CCDC146

2.81e-041913031e21de183a9c09cfb6aad3f9b948087fb6bad061
ToppCellSmart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

RIOK3 NTNG2 CEBPB

2.81e-04191303d4f77c73311d1149466bbfe4adbd6a301946ec90
ToppCellE16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CFAP210 CFAP44 CCDC146

2.81e-041913038688708c9183ebcb200596501dc30cc12073f151
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)

CFAP210 POLR3E PHF3

2.81e-041913031ecd9849d14d5ebf3daf610e83fb50820cafd3ed
ToppCellwk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

CFAP210 CFAP44 CCDC146

2.81e-04191303e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a
ToppCellmulticiliated|World / shred by cell class for turbinate

CFAP210 CFAP44 CCDC146

2.85e-041923030f89ea0deb651ca11531c51ee94e0233608d22ea
ToppCellBronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X

CFAP210 CFAP44 CCDC146

2.85e-04192303be592e661367affced9ebe80849b466e6adb3a34
ToppCellfacs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ASPM FKBP5 PRIM1

2.85e-04192303e8d47504b744040a762ec9b670a66cc060b2ae86
ToppCellE16.5-Epithelial-Epithelial_Airway|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CFAP210 CFAP44 CCDC146

2.85e-04192303bb7eb51bc079acacde42d8e55ba06d03eba2ea28
ToppCell3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CFAP210 CFAP44 CCDC146

2.85e-041923031b6cac8156e608061e1405e36e18d185b6fa8f6f
ToppCellE16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CFAP210 CFAP44 CCDC146

2.85e-04192303a50a6279371b3be682e334082637b7ab76b9a6e5
ToppCellH1299-infected|H1299 / Cell line, Condition and Strain

ASPM ANKRD12 LUC7L3

2.85e-041923039cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCellBronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X

CFAP210 CFAP44 CCDC146

2.90e-041933030b62a6ddd7c42efd9f39781971d1438501e1fa8d
ToppCellASK452-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq

CFAP210 CFAP44 CCDC146

2.90e-04193303c0d10075862ac878aa05fc49c8b73e470783bf16
ToppCellControl-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class

CFAP210 CFAP44 CCDC146

2.90e-041933030e37d454f3735edd936ee9a5f5f516ac3aad400e
ToppCell15-Trachea-Epithelial-Multiciliated_cell|Trachea / Age, Tissue, Lineage and Cell class

CFAP210 CFAP44 CCDC146

2.90e-04193303aa3acc7571405169efb656d214f3a8cbf988362e
ToppCellASK440-Epithelial-Ciliated|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq

CFAP210 CFAP44 CCDC146

2.90e-04193303a0baa8be6f590b2031fede22be588715ae458e93
ToppCellIPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class

CFAP210 CFAP44 CCDC146

2.90e-04193303ad58f5080e0ba65c845056ea6b79037b636e9c64
ToppCellwk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

CFAP210 CFAP44 CCDC146

2.94e-04194303756082a0f5953b52229bb60d40b84701cb6cb23d
ToppCellBronchial_Brush-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X

CFAP210 CFAP44 CCDC146

2.94e-041943037a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)

ASPM LRRC59 PRIM1

2.94e-041943035771a28a61f4d9b5479891f3224909ab003cb241
ToppCellASK452-Epithelial-Ciliated|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq

CFAP210 CFAP44 CCDC146

2.94e-041943035aeb44657ab6f61b1abf98af28d3397d8e44c1aa
ToppCellASK440-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq

CFAP210 CFAP44 CCDC146

2.94e-04194303c84a7fa94fb06e08aae04db56c8c313b0afde1d7
ToppCellwk_15-18-Epithelial-Proximal_epithelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

CFAP210 CFAP44 CCDC146

2.94e-04194303b0477583301dc6d9767b667bd2f8f94fbfaa6f81
ToppCell3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CFAP210 CFAP44 CCDC146

2.94e-041943034a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCellcontrol-Myeloid-Neutrophils_3|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

NTNG2 CEBPB FKBP5

2.94e-041943032218e6677dc6781a6e4ef3a315f2298cc2cd9df2
ToppCellBronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X

CFAP210 CFAP44 CCDC146

2.94e-04194303b4ce60c06568123008b1081d644733cb91c28f51
ToppCell3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CFAP210 CFAP44 CCDC146

2.94e-04194303a46238514bca920c3e3713d23c18ba24a09e2a29
ToppCell3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CFAP210 CFAP44 CCDC146

2.99e-0419530393b1559382a12cfb158aa5fac7386e38b4f87989
ToppCellNS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CFAP210 CFAP44 CCDC146

2.99e-0419530334e37cff4849696ca4ba5dd8fd2cf98fed8bc912
ToppCell3'-Broncho-tracheal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CFAP210 CFAP44 CCDC146

2.99e-041953030e763f36786515698b593e5c93f6a56619c1242d
ToppCellControl_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type

CFAP210 CFAP44 CCDC146

2.99e-0419530360067b5359174f0d1a8b5748bfc0690762e9e740
ToppCell3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CFAP210 CFAP44 CCDC146

2.99e-041953039651ee03738226ee10e901f8b9ec6a417eb9c301
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

ANKRD12 POLR3E PHF3

2.99e-04195303ed5f772c82d4dfd1c8735224446ec9feae3fb8c2
ToppCellfacs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ASPM FKBP5 PRIM1

2.99e-0419530393c345e70d6c8ff5d12fd63d73228c1700b804a0
ToppCell3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CFAP210 CFAP44 CCDC146

2.99e-04195303581b04220587e1d5198b1abd6965965ace7803e7
ToppCelldroplet-Thymus-nan-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ASPM FKBP5 PRIM1

2.99e-04195303043e2f19d95e94cd5219e2c415f322ed340aa80f
ToppCell3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CFAP210 CFAP44 CCDC146

3.03e-04196303a37ba02446eef5d1fab703204583f6550a8ec3e1
ToppCellNS-moderate-d_07-13-Epithelial-Ciliated-diff|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CFAP210 CFAP44 CCDC146

3.03e-041963039a91a6e5f93ce3bb5a0fc63677553f4c2df95c43
ToppCell3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CFAP210 CFAP44 CCDC146

3.03e-0419630389ea4d2086e1c769c5a87f1471a6cd4acabcfe33
ToppCellcritical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CFAP210 CFAP44 CCDC146

3.03e-0419630327b855c6e1ae44f16db998cf0e81bd686b9cee7e
ToppCell3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CFAP210 CFAP44 CCDC146

3.03e-04196303a156840330630e518bc85633dded6f2c3ead3b30
ToppCell3'-Distal_airway-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CFAP210 CFAP44 CCDC146

3.03e-04196303009e83c7251cf300be78b263634d233a8d972a68
ToppCellmild-Myeloid-Neutrophils_2|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

NTNG2 CEBPB FKBP5

3.03e-04196303e9f30eb8a3915c3b2af009c832bff9b349b65ae5
ToppCelldroplet-Thymus-nan-18m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ASPM FKBP5 PRIM1

3.03e-041963035ddd314d3def3776dc7da83778d41c6436ca51ac
ToppCellPSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CFAP210 CFAP44 CCDC146

3.08e-041973036865f4831eb23794fb88a8649d48d497bbae3f44
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster

ANKRD12 LUC7L3 CXADR

3.08e-0419730379b9e7f2e8e33b3c547f716be5667156c48b0dfc
ToppCellNS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CFAP210 CFAP44 CCDC146

3.08e-0419730371fea4aa6ce96c7693fa94792d08770622873850
ToppCell3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CFAP210 CFAP44 CCDC146

3.08e-0419730374a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCellH1299-infected-SARSCoV2|infected / Cell line, Condition and Strain

ASPM ANKRD12 LUC7L3

3.08e-041973030fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCellcontrol-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CFAP210 CFAP44 CCDC146

3.08e-04197303d4e963c1f82996371bf3d63578ee9fce8e00c5a8
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster

ANKRD12 LUC7L3 CXADR

3.08e-04197303d20f29088e9afd8a960d6f680075c380e550f8a7
ToppCellcontrol-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CFAP210 CFAP44 CCDC146

3.08e-04197303e453d085182364ca347cbcc9dc995c62c3353016
ToppCellControl_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type

CFAP210 CFAP44 CCDC146

3.12e-04198303e7aa42e5fbd42c68f50cda4a8f3aa464c862c007
ToppCellControl_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type

CFAP210 CFAP44 CCDC146

3.12e-04198303e6863238e022ecfb6a8e3f4b7661b376e92c5d8f
ToppCellwk_20-22-Epithelial-Proximal_epithelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

CFAP210 CFAP44 CCDC146

3.12e-0419830316c54b884500066ade05a406915f9569ca8abdfc
ToppCellParenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

CFAP210 RHOBTB1 TADA2B

3.12e-04198303cc2b5b632e73e44bb60050f0db10d8f0dbb859fa
ToppCell(11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition

ANKRD12 CCDC146 LRRFIP1

3.12e-0419830376d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCellLPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type

CFAP210 CFAP44 CCDC146

3.12e-041983036d90b541fde357fbb40f8f7d4e8628a48b679718
ToppCellcritical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CFAP210 CFAP44 CCDC146

3.12e-04198303ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40
ToppCellmild-CD4+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

ANKRD12 LUC7L3 PHF3

3.17e-041993033e4baaf4ee23f257d821194468102c00a8ad2f21
ToppCellproximal-Epithelial-Ciliated|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

CFAP210 CFAP44 CCDC146

3.17e-041993039700f06e51ddca85e482b4f9bd4a79bfcd3cfb76
ToppCellwk_20-22-Epithelial-Proximal_epithelial-Ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

CFAP210 CFAP44 CCDC146

3.17e-04199303b974b495cabbcc3934936cec846c0e2442a70ac3
ToppCellmild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

ANKRD12 LUC7L3 PHF3

3.17e-04199303f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell(10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition

ANKRD12 CFAP210 CCDC146

3.17e-0419930361b1ed2db71b96157b92b7535d1955a4033098da
ToppCellmedial-Epithelial-Ciliated-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

CFAP210 CFAP44 CCDC146

3.17e-04199303526002f16bbf61cf086278d45a401cc0b0b757a8
ToppCellproximal-3-Epithelial-Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

CFAP210 CFAP44 CCDC146

3.17e-041993031188afad6fd5f01f9aeba225f611f38b237dd2c9
ToppCell10x_3'_v3-blood_(10x_3'_v3)-myeloid|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

CEBPB FKBP5 LRRFIP1

3.17e-04199303126a0ebd40e55c0dfb5e7c7dd8fdd733da6aa323
ToppCellmedial-Epithelial-Ciliated|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

CFAP210 CFAP44 CCDC146

3.17e-04199303a2daa42b100c422dc8c04fb7d2ebf54293eef574
DrugN6,2-O-dibutyryladenosine 3,5-cyclic monophosphate sodium salt; Down 200; 2uM; MCF7; HT_HG-U133A_EA

ATP6V1C1 PHF20L1 VWA8 PHF3 FKBP5

5.79e-06199305959_DN
DrugDigoxin [20830-75-5]; Down 200; 5.2uM; HL60; HT_HG-U133A

RHOBTB1 RHOBTB2 PRIM1 U2SURP

9.40e-051833042423_DN
DrugHelveticoside [630-64-8]; Down 200; 7.4uM; HL60; HT_HG-U133A

ATP6V1C1 RHOBTB1 PRIM1 U2SURP

1.00e-041863042192_DN
DrugLanatoside C [17575-22-3]; Down 200; 4uM; HL60; HT_HG-U133A

RHOBTB1 RHOBTB2 PRIM1 U2SURP

1.09e-041903042193_DN
DrugLanatoside C [17575-22-3]; Down 200; 4uM; PC3; HT_HG-U133A

RHOBTB1 RHOBTB2 U2SURP LRRFIP1

1.11e-041913044328_DN
DrugMethionine sulfoximine (L) [15985-39-4]; Up 200; 22.2uM; MCF7; HT_HG-U133A

ATP6V1C1 CFAP44 PHF3 RHOBTB2

1.13e-041923042831_UP
DrugPipemidic acid [51940-44-4]; Down 200; 13.2uM; PC3; HT_HG-U133A

PHF3 FKBP5 RHOBTB2 MTSS2

1.13e-041923046752_DN
DrugGriseofulvin [126-07-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A

ATP6V1C1 SF3B1 PHF3 FKBP5

1.18e-041943042293_DN
Drugradicicol, diheterospora chlamydosporia; Down 200; 0.1uM; HL60; HT_HG-U133A

RHOBTB1 POLR3E FKBP5 U2SURP

1.20e-041953041160_DN
DrugEthosuximide [77-67-8]; Down 200; 28.4uM; HL60; HG-U133A

RIOK3 ATP6V1C1 LUC7L3 U2SURP

1.22e-041963041433_DN
DrugIdoxuridine [54-42-2]; Down 200; 11.2uM; HL60; HG-U133A

RIOK3 TRAF3 PHF20L1 U2SURP

1.25e-041973041980_DN
DrugFlunarizine dihydrochloride [30484-77-6]; Up 200; 8.4uM; MCF7; HT_HG-U133A

TRAF3 ANKRD12 PHF20L1 PHF3

1.27e-041983047013_UP
DrugEpivincamine [6835-99-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A

ATP6V1C1 PHF20L1 PHF3 RHOBTB2

1.27e-041983046838_DN
DrugBrinzolamide [138890-62-7]; Down 200; 10.4uM; HL60; HG-U133A

TRAF3 LRRC59 ANKRD12 PHF20L1

1.27e-041983041615_DN
DrugTubocurarine chloride pentahydrate (+) [6989-98-6]; Down 200; 5.2uM; HL60; HG-U133A

RIOK3 TRAF3 ANKRD12 PHF20L1

1.30e-041993041738_DN
DrugTrimethylcolchicinic acid [3482-37-9]; Down 200; 11.6uM; MCF7; HT_HG-U133A

ERCC3 PHF3 RHOBTB2 U2SURP

1.30e-041993042802_DN
Diseasedevelopmental and epileptic encephalopathy 64 (implicated_via_orthology)

RHOBTB1 RHOBTB2

9.99e-072302DOID:0070375 (implicated_via_orthology)
Diseaseocular hypertension, response to triamcinolone acetonide

RIOK3 VWA8

1.14e-0349302EFO_0006954, EFO_1001069
DiseasePeripheral Nervous System Diseases

ERCC3 RHOBTB2

1.38e-0354302C4721453
Diseaseobstructive sleep apnea

ATP6V1C1 PRIM1

2.06e-0366302EFO_0003918
Diseaselymphocyte:monocyte ratio

CEBPB FKBP5 TADA2B

3.07e-03288303EFO_0600088
Diseaseurate measurement, bone density

RHOBTB1 LUC7L3 POLR3E RHOBTB2

3.41e-03619304EFO_0003923, EFO_0004531
Diseasehepatocellular carcinoma (is_marker_for)

ASPM CEBPB SF3B1

3.48e-03301303DOID:684 (is_marker_for)

Protein segments in the cluster

PeptideGeneStartEntry
DKDIDRYKERDKHKD

ANKRD12

1021

Q6UB98
KAYSIENARRKREHD

CFAP44

921

Q96MT7
KYIRAREAGKHERIK

ASPM

3061

Q8IZT6
RKYERKHEEREIKER

ST13P5

236

Q8NFI4
KKAKEHNERDRRIYA

FKBP5

396

Q13451
EKAEEKERRRKEYDA

LRRC59

191

Q96AG4
LDKDHAKEYKRARHE

MTSS2

121

Q765P7
YKHRSKSRDREQDRK

LUC7L3

361

O95232
EAESDVKHRTRDYKK

PRIM1

371

P49642
RKKRREEKYEKEVHH

CXADR

261

P78310
TVDKHSDEYKIRRER

CEBPB

266

P17676
KKKSRKRHYEDEEDD

ERCC3

11

P19447
YLDKADAKHREREAA

POLR3E

141

Q9NVU0
RQYEEKNKEFEREKH

LRRFIP1

211

Q32MZ4
KDKERREKRDKDHYR

PHF20L1

551

A8MW92
KKEKHVRFEVRDRFA

NTNG2

206

Q96CW9
RKAVDDFRHKARENK

ATP6V1C1

231

P21283
AEYEAARHKREKRKE

TADA2B

306

Q86TJ2
DHYQRARKEREKEDY

RHOBTB2

676

Q9BYZ6
ARKEREKEDYLHLKR

RHOBTB2

681

Q9BYZ6
DHYQRVKREREKEDI

RHOBTB1

661

O94844
EHYRDKLLQREKEKE

U2SURP

876

O15042
YHDELSRKQREKERD

CCDC146

346

Q8IYE0
QIKEHEEEEERRKKY

CFAP210

221

Q0VFZ6
ERRKQKEYFEKHRLK

C12orf40

16

Q86WS4
YSEERRSARLHEKKE

RIOK3

211

O14730
DLRDHVEKACKYREA

TRAF3

161

Q13114
KIADREDEYKKHRRT

SF3B1

111

O75533
EKSKHREGEKDRDRY

PHF3

2011

Q92576
HYAGLKDVAEERKRK

SPTB

1671

P11277
DYRKKLLEHKEIDGR

PSMC6

11

P62333
RYDKLLRDHTKKELD

VWA8

211

A3KMH1
HEDLNKADNRKRYKE

USP8

881

P40818